Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, February 13, 2010
Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases
Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment